Delivery Order SPE2D021D0004-SPE2D025F0200

Award Date 1/30/25
Potential Completion Date 3/3/25
Potential Value $1.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,460.60 and covers the delivery of "ANTIDOTE TREATMENT" pharmaceutical products to military healthcare facilities nationwide. The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,358.75, is a delivery order for an unspecified "ANTIDOTE TREATMENT" product under contract number SPE2DX15D9383. The contract has a firm fixed price and a completion date of July 15, 2024. The award was made by the Defense Logistics Agency (DLA), specifically the Medical Supply Chain division, with no...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,460.60 firm fixed-price delivery order is for an "Antidote Treatment Kit, Cyanide, Sodium N" and has a performance period ending on September 20, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price purchase order contract awarded by the Medical Supply Chain agency of the U.S. Department of Defense (DOD) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $2,015.25 and requires the delivery of antidote treatment products by April 25, 2024. DMS Pharmaceutical Group holds a separate indefinite delivery contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,718.76, is a firm fixed-price delivery order for an Antidote Treatment Kit, Cyanide Sodium N under the DLA's SPE2D program. The contract has an ultimate completion date of December 24, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract, valued at $80,285.70, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order that does not have a set-aside designation. It is part of a larger indefinite delivery contract (IDC) with a...
This federal contract award, valued at $1,105.08, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a delivery order under the SPE2DB program, which is a single-award Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999 and valid through November 2026. The contract covers the delivery of a range of pharmaceutical products, including branded and generic...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,294.20 firm fixed-price delivery order falls under a larger $499,999,999 indefinite delivery contract (IDC) with the DLA's Medical Supply Chain division, through which DMS Pharmaceutical Group provides a wide range of pharmaceutical products and medical supplies to support the recurring medical...
This federal contract award is to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $46,037.55, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The award is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which runs through December 31, 2025. Under this contract, DMS Pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,897.65 firm fixed-price delivery order is for the supply of various pharmaceutical products, including flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and other common...
  • SPE2D021D0004
    Indefinite Delivery Contract
  • SPE2D021D0004-SPE2D025F0200
    Delivery Order

This federal contract award, identified as SPE2D021D0004|SPE2D025F0200, was made by the Medical Supply Chain office of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,606.66 fixed-price delivery order is for the provision of "ANTIDOTE TREATMENT" products to support the recurring medical supply needs of military healthcare facilities.

The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure this direct federal award. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a diverse array of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense (DoD). This contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.

Generated 5/4/25, 12:53 AM